- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Varian strikes supply agreements in oncology
HealthTrust Purchasing Group and Varian Medical Systems have renewed and expanded a three-year agreement to supply HealthTrust members with advanced systems for treating cancer with radiotherapy through the year 2003. Mid Atlantic Group Network of Shared
HealthTrust Purchasing Group and Varian Medical Systems have renewed and expanded a three-year agreement to supply HealthTrust members with advanced systems for treating cancer with radiotherapy through the year 2003. Mid Atlantic Group Network of Shared Services (MAGNET) has also renewed a preferred pricing agreement for Varian to supply members with radiotherapy equipment. The contracts cover a range of equipment including Ximatron treatment simulators, linear accelerators, and SmartBeam IMRT (intensity-modulated radiation therapy), a highly precise radiation therapy technology.
HealthTrust is one of the nation's largest healthcare group purchasing organizations with a current membership of more than 600 facilities. Members of MAGNET, one of the oldest, largest, and most experienced shared service/GPOs in the U.S., serve over 775 hospitals and 1100 nursing homes, along with more than 5000 physicians and 1000 allied healthcare organizations in 20 states.
© 2001 Miller Freeman Inc.
3/28/01, Issue # 1506, page 6.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
CT Study Links Pleural Effusion and Higher 30-Day Mortality Rates in Patients with COVID-19
October 1st 2024In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.
